Roberto Martinez’s Perspectives

12 total results. Page 1 of 1.

Investigations Blog
FCA Enforcement & Compliance Digest — Fall 2024 False Claims Act Newsletter
Investigations Blog
Teva Pharmaceuticals Agrees to Pay $450 Million to Resolve FCA Claims
Investigations Blog
US Supreme Court Declines to Consider AKS ‘Willfulness’ Question
Investigations Blog
Medical Device Manufacturer THD Pays $700,000 to Resolve FCA Allegations
Investigations Blog
Federal Court Permits Investors to Resume Kickback Suit Against Teva
Alerts
Relator Calls on Supreme Court to Define Standard for a ‘Willful’ Kickback under Federal Anti-Kickback Statute
Investigations Blog
Health Care Fraud and Money Laundering of $18 Million Leads to Prison Sentence for New York Pharmacy Owners
Investigations Blog
Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit
Alerts
Navigating Trade Secrets and Noncompetes: Analysis of the Year’s Key Cases and Trends
Alerts
Sliding Into Your DMs With a Court Summons
Consumer Products Watch
You Can(not) Say That Again: Using a 30(b)(6) Corporate Witness’s Deposition Testimony at Trial
Consumer Products Watch
Practice Pointer: How Manufacturers Can Protect Their Lobbying Efforts With the Noerr-Pennington Doctrine